Popular Articles
Natural Remedies

Merck Issues Statement On WHO Study Showing First Evidence That Elimination Of River Blindness Is Feasible In Africa
Merck & Co., Inc. issued the following statement in response to study results published today by the World Health Organization offering the first evidence that elimination of the tropical disease river blindness (onchocerciasis) in Africa is feasible with treatment with ivermectin (registered trademark Mectizan®). As the discoverer and manufacturer of Mectizan, Merck decided in 1987 to donate the drug to all who need it for as long as necessary until river blindness is eliminated as a public health problem. The Merck Mectizan Donation Program is one of the longest-running disease-specific drug donation and public/private partnership programs in history.
generic viagra online
Health Care Industry Increases Lobbying Spending
Drug companies "boosted their lobbying in Washington during the three months (that) ended June 30 amid a flurry of congressional action on health care," while overall, "Washington"s lobbying business continued to slump as the economy pinched budgets at some big companies and trade associations," The Wall Street Journal reports. "Drug manufacturers increased lobbying spending 13% to $68 million in the second quarter from a year earlier, according to the data ò€¦ Overall, the health-care sector reported a 5% increase in lobbying expenditures to $133 million, making it the single largest spender on lobbying of the 10 major industry sectors tracked by the Center for Responsive Politics. Health-insurance companies increased lobbying activity by 11% to $7.8 million, according to the data" (Mullins and Farnam, 8/3).
News of the day
IQ Explains Some Of The Difference In Heart Disease Between People Of High And Low Socio-economic Status
A unique study looking at the difference in cardiovascular disease (heart disease and stroke) and life expectancy between people of high and low socio-economic status has found that a person"s IQ may have a role to play.
Nutrition

APHA Commends Senate Passage Of Tobacco Legislation, USA

Statement from Georges C. Benjamin, MD, FACP, FACEP (E), Executive Director, American Public Health Association, "The American Public Health Association applauds the Senate for today passing the Family Smoking Prevention and Tobacco Control Act. The legislation will protect the health of Americans, particularly children, by giving the Food and Drug Administration (FDA) the authority to regulate tobacco products. "For decades the tobacco companies have marketed their deadly products to our children, deceived consumers about the harm their products cause, and failed to take any meaningful action to make their products less harmful or less addictive. This tobacco control legislation provides an opportunity to finally end the special protection enjoyed by the tobacco industry and protect our children and the nation"s health instead. "The legislation meets the high standard established by the public health community for tobacco regulation and will give the FDA authority to effectively regulate the manufacturing, marketing, labeling, distribution and sale of tobacco products. "APHA looks to the House to quickly pass the Senate bill and send the president this long-awaited legislation for his signature. With so much at stake, we cannot afford to wait any longer to take action to protect the health of our children and our nation." American Public Health Association


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):